The global next generation sequencing (NGS) sample preparation Market is expected to reach USD 6,630.0 Million by 2027, according to a new report by Emergen Research.
The global next generation sequencing (NGS) sample preparation Market is expected to reach USD 6,630.0 Million by 2027, according to a new report by Emergen Research. The growth of this market is attributed to the increasing demand for personalized medicine and the rapid adoption of NGS-based applications in oncology.
The rising number of sequencing projects, government initiatives to promote precision medicine, and the declining cost of sequencing are some of the other factors that are expected to fuel market growth over the forecast period. However, the lack of skilled personnel is expected to restraint market growth over the forecast period.
Numerous advantages of high-performance sequencing over traditional approaches have contributed to its increasing popularity. Some of the advantages are shorter time to results, low input amount of DNA required, higher sensitivity, and portability. However, preparing quality samples is critical for successful sequencing and data interpretation. Hence, considerable emphasis is placed on sample preparation during NGS workflow.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/12
This NGS technology has drawn the interest of pharmaceutical and biotechnology companies, research institutes, and academic organizations. The demand for NGS-based diagnostic tests has grown rapidly in recent years as they offer a more comprehensive and accurate approach to disease diagnosis than traditional methods. However, the high cost of NGS technology and the lack of skilled personnel are restraining market growth.
Top players are engaged in various strategies such as product launches, expansions, acquisitions, and partnerships to gain a competitive edge in the market. For instance, in March 2019, Thermo Fisher Scientific launched an Ion Chef System for automated library preparation of DNA and RNA samples for next-generation sequencing.
In November 2018, Qiagen N.V. acquired Mologic Ltd., a UK-based developer of molecular diagnostics. This acquisition is expected to strengthen Qiagen’s position in the molecular diagnostics market and expand its product portfolio.
Some Key Highlights from the Report
- On the basis of technology, the market is bifurcated into whole genome sequencing, exome sequencing, RNA sequencing, and target sequencing. The whole genome sequencing segment is expected to hold the largest market share over the forecast period. This is attributed to the rising demand for whole genome sequencing in disease diagnosis and drug development applications.
- On the basis of application, the market is bifurcated into diagnostics, therapeutics, precision medicine, and others. The therapeutics application segment is expected to grow at the fastest CAGR over the forecast period. This is attributed to the fact that NGS-based applications are being increasingly used in drug development and clinical research.
- On the basis of end user, the market is bifurcated into hospitals and clinics, academic and research institutes, pharmaceutical and biotechnology companies, and others. The hospitals and clinics segment is expected to hold the largest market share over the forecast period. This is attributable to the increasing use of NGS-based applications in clinical diagnosis.
- North America is expected to hold the largest market share over the forecast period. This is attributed to the presence of a large number of sequencing projects in the region and the rapid adoption of NGS-based applications in precision medicine. Moreover, the increasing government funding for precision medicine initiatives is expected to fuel market growth in the region.
- The Asia Pacific region is expected to grow at the fastest CAGR over the forecast period. This is attributable to the increasing government initiatives to promote precision medicine, rising R&D activities in the biotechnology and pharmaceutical industries, and the growing number of sequencing projects in the region.
- Key participants include Agilent Technologies, Bio-Rad Laboratories, Inc., BGI; Biomatters Ltd., Congenica Ltd, Eurofins Scientific, DNASTAR, F. Hoffmann-La Roche Ltd., Genomatix GmbH, Thermo Fisher Scientific, and Foundation Medicine, among others, among others.
Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/ngs-sample-preparation-market
Emergen Research has segmented the global next generation sequencing (NGS) sample preparation market on the basis of workflow, application, end-users, and region:
Workflow Outlook (Revenue, USD Billion; 2017-2027)
- NGS Library Preparation Kit
- Semi-Automated Library Preparation
- Automated Library Preparation
- Colonial Amplification
Application Outlook (Revenue, USD Billion; 2017-2027)
- Oncology
- Clinical Investigation
- Reproductive Health
- HLA Typing/Immune System Monitoring
- Metagenomics, Epidemiology, & Drug Development
- Agrigenomics & Forensics
- Consumer Genomics
End-Users Outlook (Revenue, USD Billion; 2017-2027)
- Academic Research
- Clinical Research
- Hospitals & Clinics
- Pharma & Biotech Entities
- Others
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S.
- Canada
- Europe
- Germany
- UK
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/12
Explore More Reports Emergen Research:
Interventional Cardiology Devices Market
Electric Vehicle Fluids and Lubricants Market
Structural Insulated Panels Market
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trend’s existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Emergen Research Media Citations: https://www.emergenresearch.com/media-citations
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Press Release Available @ https://www.emergenresearch.com/press-release/global-next-generation-sequencing-sample-preparation-market